HSL (hormone-sensitive lipase) is a key enzyme in the mobilization of fatty acids from acylglycerols in adipocytes as well as non-adipocytes. In adipocytes, catecholamines stimulate lipolysis mainly through PKA (protein kinase A)-mediated phosphorylation of HSL and perilipin, a protein coating the lipid droplet. The anti-lipolytic action of insulin is mediated mainly via lowered cAMP levels, accomplished through activation of phosphodiesterase 3B. Phosphorylation of HSL by PKA occurs at three sites, the serines 563, 659 and 660, both in vitro and in primary rat adipocytes. Phosphorylation of Ser-659 and -660 is required for in vitro activation as well as translocation from the cytosol to the lipid droplet, whereas the role of the third PKA site remains elusive. Adipocytes isolated from homozygous HSL-null mice, generated in our laboratory, exhibit completely blunted catecholamine-induced glycerol release and reduced fatty acid release, suggesting the presence of additional, although not necessarily hormone-activatable, triacylglycerol lipase(s). Basal hyperinsulinaemia, release of exaggerated amounts of insulin during glucose challenges and retarded glucose disposal during insulin tolerance tests suggest that HSL-null mice are insulin resistant. Liver, adipose tissue and skeletal muscle appear all to be sites of impaired insulin sensitivity in HSL-null mice.
Introduction
The major site for storage of triglycerides (triacylglycerols) is the white adipose tissue, although limited triglyceride stores appear to be present in most cell types. The triglyceride stores of non-adipocytes most likely function as an internal energy reserve and as a source of fatty acids for membrane biosynthesis. Furthermore, it seems clear that fatty acids and derivatives thereof participate in various signalling events. Hydrolysis of adipocyte triglycerides occurs through three consecutive reactions and is catalysed by two enzymes: HSL (hormone-sensitive lipase) [1] and monoglyceride lipase. HSL alone catalyses the hydrolysis of triglycerides and diglycerides, whereas the participation of monoglyceride lipase is required to obtain complete hydrolysis of monoglycerides [2] . HSL and monoglyceride lipase appear to play a key role in the hydrolysis of acylglcyerols also in non-adipocytes, but the involvement of additional lipases can be anticipated.
HSL
HSL exhibits a broad substrate specificity and besides acylglycerols it hydrolyses cholesteryl esters, retinyl esters, steroid esters and p-nitrophenyl esters. However, it lacks phospholipase activity. The cholesteryl ester hydrolase activity of HSL is twice as high as the activity towards triglycerides, and thus relatively much higher than that of bile-salt-stimulated lipase, the only other known mammalian lipase exhibiting cholesteryl ester hydrolase activity [3, 4] . The relative maximal rates of hydrolysis, i.e. 1:11:2.1:23 for trioleoin, diolein, cholesteryl oleate and p-nitrophenyl butyrate respectively, are based on measurements performed in vitro using purified, non-phosphorylated enzyme [5] . Phosphorylation under in vitro conditions increases moderately the activity against triglycerides and cholesteryl esters, whereas the activity against di-and monoglycerides is unaffected. The extent to which this reflects what happens in vivo is not known.
To date three isoforms of HSL have been identified, ranging in size from 84 to 130 kDa [6] [7] [8] . These arise from the same gene through the use of alternative promoters. Exons 1-9 encode the amino acids that are common to all isoforms [9] . In addition to these, several upstream non-coding and coding exons appear to be used in a mutually exclusive and tissue-specific manner (Figure 1 ). Two promoters have been identified and characterized, i.e. the promoters upstream of exons B [10] and T [11, 12] . The promoter upstream of exon B appears to be utilized in adipocytes as well as several other tissues, whereas the promoter upstream of exon T drives expression specifically in testis.
A domain structure model for the adipocyte isoform of HSL has been worked out using limited proteolysis studies, spectroscopic analyses during denaturation, molecular modelling and site-directed mutagenesis [5, [13] [14] [15] [16] . According to this, adipocyte HSL is composed of two major structural domains, an N-terminal domain, which is variable between isoforms, and a C-terminal catalytic domain, which is identical in all known HSL isoforms ( Figure 1 ). The catalytic domain harbours the active site, including the residues of the (1-9) are represented in the majority of adipocyte HSL transcripts. Exon T is a testis-specific exon, whereas exon A is represented in a minor fraction of adipocyte HSL transcripts. Exons 1-4 encode the N-terminal domain, whereas exons 5-9 encode the catalytic domain. Ser-423, Asp-703 and His-733 are the catalytic triad residues. Exon 7 and part of exon 8 encode the regulatory module, which contains all known phosphorylation sites of HSL.
catalytic triad, as well as a regulatory module with all known phosphorylation sites of HSL. In a molecular modelling approach where the organization of predicted secondary structure elements in HSL was compared with the actual organization of such elements in enzymes with known threedimensional structure belonging to the same superfamily, i.e. the carboxylesterase B superfamily, it was shown that the catalytic core adopts the α/β-hydrolase fold [14] . The correctness of the model was confirmed as the structure of brefeldin A esterase was solved [17] . After correcting several errors in the cDNA sequence of this enzyme a sequence identity of 37% to the catalytic core of HSL was revealed. The function of the N-terminal domain is poorly understood but is has been implicated in protein-protein and proteinlipid interactions. It has for instance been demonstrated that the N-terminal domain interacts with adipocyte lipid binding protein (ALBP), an intracellular fatty acid carrier [18] . With regard to subunit composition, sedimentation equilibrium analyses have shown that HSL is a homodimer in solution [16] .
Regulation of adipocyte lipolysis by catecholamines and insulin
Adipocyte lipolysis is acutely regulated by hormones, neurotransmitters and other effector molecules and HSL is one of the major targets of this regulation. Catecholamines are important stimulators of lipolysis, whereas insulin is believed to be the most important anti-lipolytic hormone ( Figure 2 ). Binding of agonists to the β-adrenergic receptors, coupled to adenylate cyclase via the stimulatory G-protein, leads to an increased production of cAMP and activation of PKA (protein kinase A). The two main targets for PKA phosphorylation are HSL and the perilipins, which are proteins covering the lipid droplets of adipocytes [19] . PKA phosphorylation of HSL and the perilipins causes a dramatic increase in lipolysis. The ability of insulin to antagonize hormone-induced lipolysis is to a large extent accounted for by its ability to lower cAMP levels and therefore PKA activity. The decrease in cAMP is mainly the result of an insulin-mediated activation of phosphodiesterase 3B [20] .
Mechanisms behind PKA-mediated activation of lipolysis
PKA phosphorylates HSL at three serine residues: 563, 659 and 660 (numbering for rat HSL) [21] . In vitro PKA phosphorylation of HSL can be monitored as an increased activity against triglyceride and cholesteryl ester substrates. In vivo, PKA phosphorylation is known to result in translocation of HSL from a cytosolic location to a location at the lipid droplet [22, 23] . For a long time Ser-563 was believed to be the only PKA site of HSL, and thus the site that confers activity control. However, the observations that mutagenesis of Ser-563 did not abolish the ability of HSL to become activated upon phosphorylation by PKA, and that upon two-dimensional tryptic phosphopeptide mapping spots other than those that could be accounted for by phosphorylation of Ser-563 and Ser-565 were generated both in vitro and in vivo, led to the identification of two Binding of agonists to β-adrenergic receptors (β-AR), coupled to the adenylate cyclase (AC) via the stimulatory G-protein (G s ), increases the levels of cAMP. This in turn leads to activation of PKA, which phosphorylates HSL at three serine residues and also perilipin A on multiple sites. PKA phosphorylation of HSL causes translocation from the cytosol to the lipid droplet, whereas phosphorylation of perilipin by PKA alleviates the barrier function of this protein and prompts its active participation in the lipolytic process. β 3 -Adrenergic agonists have been suggested to stimulate lipolysis via a concerted activation of PKA and ERK1/2 MAP kinase, accomplished through dual coupling of the β 3 -adrenergic receptor to G s and G i . In hormonally quiescent adipocytes, HSL appears to be phosphorylated at a fourth serine residue, presumably by the 5 -AMP-activated protein kinase (5 AMPK). The anti-lipolytic action of insulin can to a large extent be accounted for by its ability to lower cAMP levels. This in turn is mainly the result of an insulin-mediated activation of phosphodiesterase 3B. TG, triglycerides; DG, diglycerides; MG, monoglycerides; MGL, monoglyceride lipase.
novel PKA sites, Ser-659 and Ser-660. All three PKA sites of HSL are phosphorylated both in vivo in response to stimulation of rat adipocytes by isoprenaline and in vitro upon incubation with PKA. Mutagenesis of both Ser-659 and Ser-660 completely abolishes activation of HSL in vitro [21] as well as translocation in vivo [23a], whereas mutagenesis of Ser-563 has no effect on either of these. Thus Ser-659 and Ser-660 are the activity-controlling sites of HSL, whereas the role of the third PKA site (Ser-563) remains elusive.
As mentioned above, the perilipin proteins are, besides HSL, major targets for PKA phosphorylation upon β-adrenergic stimulation of adipocytes. The perilipins are a family of closely related proteins that are abundantly expressed in adipocytes [19, 24] . They are located on the surface of the lipid droplet, where they seem to serve a dual role as suppressor of basal lipolysis and as a necessary component for full lipolytic stimulation to occur. The barrier function of perilipin is suggested by studies showing that the lipolytic action of tumour necrosis factor-α is mediated via down-regulation of the perilipins, an action that can be prevented by retroviral overexpression of perilipin [25] . Further support comes from studies in which perilipin A has been ectopically expressed in either 3T3-L1 adipocytes or Chinese hamster ovary cells, manipulations that result in increased storage of triglycerides [26] [27] [28] . The essential role of perilipin in PKA-mediated lipolysis was revealed in the phenotype of the perilipin-knockout mouse models, which displayed attenuated β-adrenergic-induced lipolysis [29, 30] . Subsequent studies where perilipins were introduced into Chinese hamster ovary cells provide further support for the essential role of perilipin A in lipolysis regulation and furthermore show that it is the unique N-terminal part of perilipin A that is responsible for this effect [28, 31] . Moreover, it was recently demonstrated that in the absence of expression of fully phosphorylatable perilipin A, translocation of HSL fails [32] .
It should be emphasized that the above applies to lipolysis regulation in adipocytes. To what extent it is true also for lipolysis regulation in non-adipocytes remains to be established. For instance, although HSL seems to be widely expressed among tissues, perilipin expression has so far been convincingly demonstrated only in adipocytes and steroidogenic tissues.
PKA-independent mechanisms for control of lipolysis
There is much to suggest that catecholamines activate not only PKA, but also the ERK (extracellular-signal-regulated kinase) 1/2 MAP (mitogen-activated protein) kinase. It has been shown that this pathway is activated through β 3 -adrenergic receptor coupling to G i , raising the possibility that dual G s /G i -protein coupling to this receptor allows PKA and ERK1/2 to work in concert to stimulate lipolysis [33] . Based on experiments where HSL and various HSL mutants were expressed in Chinese hamster ovary cells and then subjected to in vitro phosphorylation by activated MAP kinase, it was proposed that ERK1/2 phophorylates HSL on Ser-600 and that this leads to increased activity of the enzyme [34] . However, the phosphorylation of this site by ERK1/2 in isolated primary adipocytes remains to be demonstrated. In this context it is worth mentioning that it has recently been demonstrated that protein kinase C stimulation of HSL, mediated at least partly via the ERK pathway, is involved in contraction-induced activation of HSL in skeletal muscle [35] .
In addition to the three PKA sites, one additional phosphorylation site in HSL, Ser-565, has been shown to be phosphorylated in vitro as well as in isolated primary adipocytes [36, 37] . This site appears to be phosphorylated to a high degree already in non-stimulated adipocytes and phosphorylation of this site in vitro does not directly affect enzyme activity. However, it has been shown in vitro that prior phosphorylation of HSL by 5 -AMP-activated kinase, which is the kinase proposed to be responsible for phosphorylation of this site, prevents subsequent phosphorylation by PKA and vice versa [36] . Moreover, preincubation of adipocytes with the AMP-mimicking agent AICAR (5-aminoimidazole-4-carboxamide riboside) inhibits isoprenaline-induced lipolysis [38, 39] . Based on the mutual exclusion between phosphorylation of Ser-565 and the PKA sites, phosphorylation of the AMP kinase site has been proposed to play an anti-lipolytic role [36] .
HSL-knockout mice
During recent years several groups, including ours, have generated and characterized HSL-null mice [40] [41] [42] [43] . The most striking aspects of the phenotype of these mice is male infertility due to oligospermia, lack of obesity and ability to survive an overnight fast. Lipolysis studies performed on isolated adipocytes show that catecholamineinduced glycerol release is almost completely blunted and catecholamine-induced fatty acid release is significantly reduced in HSL-null adipocytes compared with wild-type cells. Basal lipolysis, however, is unaffected in the HSL-null mice. This suggests the presence of one or several additional intracellular triglyceride lipases in adipose tissue, which can at least partly compensate for the lack of HSL. This was also suggested by studies performed on mouse embryonic fibroblast-derived adipocytes, prepared from HSL-null mice [44] . The additional lipase(s) does not necessarily need to be activatable, since it is possible that perilipin phosphorylation, with the consequent loss of the barrier function of this protein, allows alternative lipases access to the lipid droplet, regardless of whether these are themselves activated by PKA or not. The nature of the additional lipase(s) remains to be elucidated. The finding that diglycerides accumulate in adipocytes of HSL-null mice [42, 43] indicates that putative additional lipases are mainly triglyceride lipases with no or little diglyceride lipase activity.
In the basal state, HSL-null mice are slightly hyperglycaemic and hyperinsulinaemic, suggesting that lack of HSL leads to impaired insulin sensitivity [43, 45] . This is further suggested by the release of exaggerated amounts of insulin during glucose challenges and retarded glucose disposal during insulin tolerance tests. The insulin resistance is observed in adipose tissue (impaired insulin-stimulated lipogenesis), skeletal muscle (impaired insulin-stimulated glucose uptake) as well as in liver (diminished ability of insulin to suppress endogenous glucose production). In perifusion experiments, isolated islets from HSL-null mice show an exaggerated response to glucose, suggesting adaptation to the insulin-resistant state, which is further supported by increased (2-fold) β-cell mass in null islets. The lack of a secretory defect in our HSL-null model, which has been extensively confirmed in static incubations of islets in response to a variety of secretagogues, at different ages and in both genders, argues against a role for HSL in stimulus-secretion coupling (M. Fex, M. Sörhede-Winzell, C.S. Olafsson, P. Rorsman, C. Holm and H. Mulder, unpublished work). However, it should be pointed out that Roduit et al. [45] have published data on the importance of HSL for glucosestimulated insulin secretion. The reason for the conflicting data is unknown, but it is possible that it relates to the different genetic backgrounds of the animals used in the two studies. With regard to plasma lipids and lipoproteins, both NEFA (non-esterified fatty acids) and triglycerides are markedly decreased in the fasted state, whereas total cholesterol and high-density lipoprotein cholesterol are increased in HSLnull mice compared with wild-type mice [46] . In agreement with the role of HSL in supplying the liver with NEFA, HSL-null mice display decreased hepatic very-low density lipoprotein production and dramatically reduced hepatic triglyceride stores and ketogenesis. Lipoprotein lipase is up-regulated in muscle tissues and white adipose tissue, presumably reflecting an attempt to compensate for the decreased delivery of NEFA to these tissues [46] . All in all, HSL-null mice exhibit an anti-atherogenic lipoprotein profile, but it remains to be established whether this is indeed reflected in protection against development of atherosclerotic lesions. In addition to the role of HSL in supplying NEFA for hepatic very-low density lipoprotein synthesis, another possible mechanism whereby HSL could be involved in atherogenesis would be via its action in macrophages. However, it has been shown that peritoneal macrophages from our HSL-null model display no defect in their ability to hydrolyse cytosolic cholesteryl esters, indicating that another enzyme is responsible for this reaction [47] .
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